INDEPENDENT NEWS

Business, Regulatory and Patents Digest

Published: Mon 16 Feb 2004 05:26 PM
Business, Regulatory and Patents Digest
Cogitations: Business, Regulatory and Patents 16 February 2004 Guest Editorial - Business, Regulatory and Patents 16 February 2004 Research charity secures cancer gene patent EC to ask for GM corn approval German cabinet approves GM Bill Genesis result no cause for alarm, exec says Future bright for local drug industry, Professor says Relax rules on embryo use, scientists say
Cogitations: Business, Regulatory and Patents 16 February 2004 Last week the British medical charity, Cancer Research UK, announced it had secured the European patent on a gene that causes hereditary breast cancer. The patent covers all efforts to sequence the Stand up for your rights!Oops, they've done it again; our Government does not seem capable of presenting a consistent message, no matter the subject. On a current topical issue, we have Solici... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6246
Research charity secures cancer gene patent A British medical research charity announced Wednesday it has secured a Europe-wide patent on a key gene that causes hereditary breast cancer, saying it had won a victory that ensures that cancer rese... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6182
EC to ask for GM corn approval The European Commission on Wednesday will ask national governments to approve the sale of a gene-modified corn made by Monsanto Co., pressing ahead with efforts to lift the region's six-year ban on ne... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6201
German cabinet approves GM Bill German Chancellor Gerhard Schröder's cabinet on has approved a bill regulating the cultivation of genetically modified organisms. The bill would make it legal for German farmers and supermarkets to se... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6221
Genesis result no cause for alarm, exec says New Zealand's largest listed biotech company, Genesis Research, has enough cash to survive just two more years unless it can significantly reduce costs or boost revenue. The company has reported a... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6230
Future bright for local drug industry, Professor says University of Otago pharmacy school dean Professor Ian Tucker believes New Zealand's pharmaceutical industry can eventually achieve major international success. Professor Tucker was one of several... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6229
Relax rules on embryo use, scientists say New Zealand researchers want the right to destroy human embryos in order to grow stem cells that might one day provide cures for conditions such as Parkinson's disease. A lineup of scientists at t... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6237

Next in Business, Science, and Tech

Geo40 partner with Maori on world-leading energy project
By: Geo40
EVRoam provides safe, reliable information for EV charging
By: NZTA
Customers not focus of replacement business at insurers
By: Financial Markets Authority
E tū: Nestle job losses “a bolt from the blue”
By: E Tu
New seabed mining project threatens endangered species
By: Greenpeace
Govt helping electric vehicle drivers to roam free
By: New Zealand Government
AA welcomes certainty for EV drivers with EVRoam launch
By: Automobile Association
ChargeNet Help to Launch Game-Changing EV Software
By: ChargeNet
FMA review sends important message to industry
By: Financial Services Council
RJ’s signs conditional agreement to acquire local brands
By: RJ's
Call to Reject Marine Mining in Endangered Dolphin Sanctuary
By: WWF-New Zealand
Coastline exploration permit setting dangerous precedent
By: Te Runanga o Ngaati Ruanui Trust
If the whale’s gone, the fireworks are on
By: Wellington City Council
Kiwis Would Pay More for Fish ‘n’ Chips to Save Dolphins
By: Whale and Dolphin Conservation Society
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media